Sam-A Pharm. Co., Ltd (KOSDAQ:009300)

Market Cap	114.32B
Revenue (ttm)	90.13B
Net Income (ttm)	19.00B
Shares Out	6.10M
EPS (ttm)	3,113.03
PE Ratio	6.02
Forward PE	n/a
Dividend	800.00 (4.27%)
Ex-Dividend Date	Dec 27, 2024

Volume	29,597
Average Volume	14,556
Open	18,810
Previous Close	19,050
Day's Range	18,620 - 19,250
52-Week Range	15,400 - 37,950
Beta	0.30
RSI	64.13
Earnings Date	Aug 14, 2025

About Sam-A Pharm.

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid con...

• Industry: Pharmaceutical Preparations
• Founded: 1945
• Employees: 300
• Stock Exchange: KOSDAQ
• Ticker Symbol: 009300

Financial Performance

In 2024, Sam-A Pharm.'s revenue was 95.58 billion, a decrease of -1.68% compared to the previous year's 97.21 billion. Earnings were 22.08 billion, an increase of 3.30%.